Real-time enrollment status for this primary central nervous system lymphoma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 11:51 AM UTC
| NCT Number | NCT04421560 |
| Recruiting Status | Recruiting |
| Condition | Primary Central Nervous System Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 37 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Dana-Farber Cancer Institute |
| Last Updated on CT.gov | February 20, 2026 (1 week ago) |
As of March 2, 2026: Clinical trial NCT04421560 is currently recruiting participants. This clinical trial study for primary central nervous system lymphoma is actively seeking new participants at 4 locations across the United States. The study is sponsored by Dana-Farber Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04421560 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04421560 was last updated 1 week ago (February 20, 2026). HelloStudys verifies this status automatically.